| Line Item | 2026-03-31 | Q/Q | Y/Y |
|---|---|---|---|
| Revenue | $1.07B | — | +19.1% |
| R&D Expense | $196.0M | — | +8.5% |
| SG&A Expense | $352.7M | — | -31.4% |
| Operating Income | $336.6M | — | +702.2% |
| Pre-tax Income | $299.2M | — | +372.5% |
| Income Tax | $6.1M | — | +134.2% |
| Net Income | $293.1M | — | +416.7% |
| EPS (Basic) | $4.73 | — | +411.2% |
| EPS (Diluted) | $4.43 | — | +391.4% |
| Line Item | 2026-03-31 | Q/Q | Y/Y |
|---|---|---|---|
| Cash & Equivalents | $1.84B | +32.5% | -0.9% |
| Accounts Receivable | $836.3M | +0.7% | +28.1% |
| Inventory | $437.5M | +4.9% | -11.2% |
| Current Assets | $4.58B | +10.0% | +11.0% |
| Total Assets | $11.86B | +1.7% | +2.8% |
| Current Liabilities | $2.25B |
| Line Item | 2026-03-31 | Q/Q | Y/Y |
|---|---|---|---|
| Operating Cash Flow | $408.2M | — | -5.0% |
| Capital Expenditures | $19.7M | — | +41.9% |
| Investing Cash Flow | $123.1M | — | +172.9% |
| Financing Cash Flow | -$78.5M | — | +90.3% |
| Free Cash Flow | $388.5M | — | -6.6% |
| +83.8% |
| Long-term Debt | $5.35B | -0.1% | -0.2% |
| Stockholders' Equity | $4.53B | +4.9% | +8.6% |